Safarinejad Mohammad Reza, Safarinejad Shiva
Urology and Nephrology Research Center, Shahid Beheshti University, MC, Tehran, Islamic Republic of Iran.
J Urol. 2009 Feb;181(2):741-51. doi: 10.1016/j.juro.2008.10.015. Epub 2008 Dec 16.
We explored the efficacy of selenium and/or or N-acetyl-cysteine for improving semen parameters in infertile men, and the associations among semen quality and the concentrations of selenium and N-acetyl-cysteine in seminal plasma.
The study included 468 infertile men with idiopathic oligo-asthenoteratospermia who were randomized to receive 200 microg selenium orally daily (selenium group of 116), 600 mg N-acetyl-cysteine orally daily (N-acetyl-cysteine group of 118), 200 microg selenium plus 600 mg N-acetyl-cysteine orally daily (selenium plus N-acetyl-cysteine group of 116) or similar regimen of placebo (control group of 118) for 26 weeks, followed by a 30-week treatment-free period. These patients provided blood samples for the measurement of serum testosterone, estradiol, follicle-stimulating hormone, luteinizing hormone, prolactin, inhibin B, selenium and N-acetyl-cysteine. Semen samples were also obtained for routine semen analysis, and the measurement of seminal plasma selenium and N-acetyl-cysteine.
In response to selenium and N-acetyl-cysteine treatment serum follicle-stimulating hormone decreased but serum testosterone and inhibin B increased. All semen parameters significantly improved with selenium and N-acetyl-cysteine treatment. Administering selenium plus N-acetyl-cysteine resulted in additive beneficial effects. A significant positive correlation existed between the seminal plasma concentrations of selenium and N-acetyl-cysteine, and semen parameters. A strong correlation was observed between the sum of the selenium and N-acetyl-cysteine concentrations, and mean sperm concentration (r = 0.67, p = 0.01), sperm motility (r = 0.64, p = 0.01) and percent normal morphology (r = 0.66, p = 0.01).
These results indicate that supplemental selenium and N-acetyl-cysteine improve semen quality. We advocate their use for male infertility treatment.
我们探讨了硒和/或N-乙酰半胱氨酸对改善不育男性精液参数的疗效,以及精液质量与精浆中硒和N-乙酰半胱氨酸浓度之间的关联。
该研究纳入了468例特发性少弱畸精子症不育男性,他们被随机分为四组,分别为每日口服200微克硒(硒组,116例)、每日口服600毫克N-乙酰半胱氨酸(N-乙酰半胱氨酸组,118例)、每日口服200微克硒加600毫克N-乙酰半胱氨酸(硒加N-乙酰半胱氨酸组,116例)或服用类似方案的安慰剂(对照组,118例),为期26周,随后为30周的无治疗期。这些患者提供血液样本以测量血清睾酮、雌二醇、促卵泡激素、促黄体生成素、催乳素、抑制素B、硒和N-乙酰半胱氨酸。还采集精液样本进行常规精液分析,并测量精浆中硒和N-乙酰半胱氨酸的含量。
经硒和N-乙酰半胱氨酸治疗后,血清促卵泡激素降低,但血清睾酮和抑制素B升高。经硒和N-乙酰半胱氨酸治疗后,所有精液参数均显著改善。同时给予硒和N-乙酰半胱氨酸产生了累加的有益效果。精浆中硒和N-乙酰半胱氨酸的浓度与精液参数之间存在显著的正相关。观察到硒和N-乙酰半胱氨酸浓度之和与平均精子浓度(r = 0.67,p = 0.01)、精子活力(r = 0.64,p = 0.01)和正常形态百分比(r = 0.66,p = 0.01)之间存在强相关性。
这些结果表明,补充硒和N-乙酰半胱氨酸可改善精液质量。我们提倡将其用于男性不育症的治疗。